Quarterly report · Q2
6095.TEDINET S100TEBI
Period2023-10-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.9bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥14.5bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥836m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥717m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥831m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥735m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥550m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥735m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥199m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥618m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥380m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥213m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥391m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥14.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥15.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥14.5bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.2bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥8.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥8.6bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥807m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥600m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥122m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥47m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.0bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.8bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥378m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.7bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.2bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥9.18 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.16 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.33 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.42 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.03 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥27.99 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥17.05 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 56.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥434,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥434,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥685m |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥6.4bn |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥6.4bn |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥15,000 |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥1.5bn |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥234m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥234m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥131m |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥419,000 |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥153m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥7.9bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥7.9bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥434,000 |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥1.5bn |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥657m |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥5.7bn |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥5.7bn |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥2m |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥243m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥3m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥40m |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥300,000 |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥94m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥5m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥1.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 519
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for bonuses sga | Prior1YTDDuration | 64433000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 99928000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 2419000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 1785000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 78760000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 65185000 | JPY |
| Point card certificates expenses sga | Prior1YTDDuration | 282679000 | JPY |
| Point card certificates expenses sga | CurrentYTDDuration | 298447000 | JPY |
| Provision for point card certificates sga | Prior1YTDDuration | -8183000 | JPY |
| Provision for point card certificates sga | CurrentYTDDuration | -77660000 | JPY |
| Commission fee sga | Prior1YTDDuration | 369997000 | JPY |
| Commission fee sga | CurrentYTDDuration | 436237000 | JPY |
| Amortization of goodwill sga | Prior1YTDDuration | 283721000 | JPY |
| Amortization of goodwill sga | CurrentYTDDuration | 154743000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 2115000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 5920000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember | 5709916000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember | 240426000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember | 1178698000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 7129040000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 7129040000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember | 1795000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember | 2566000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember | 300000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 4661000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -4661000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember | 5711711000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember | 242992000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember | 1178998000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 7133702000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -4661000 | JPY |
| Net sales | Prior1YTDDuration | 7129040000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember | 1320599000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember | -40191000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember | 93698000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1374107000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -657139000 | JPY |
| Operating income | Prior1YTDDuration | 716967000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember | 6409271000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember | 233633000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember | 1207317000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 7850221000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 7850221000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember | 15000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember | 419000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 434000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |